Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 300 of 385 entries
View as:

The Efficacy and Safety of Different Combination Regimens of Inetetamab in First-line Treatment of HER2 Positive Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06641544 Org: User:
Start: 10/17/24 End: 12/31/27 Due: 12/31/28

Effect of Edaravone on Radiation-induced Temporal Lobe Necrosis

Phase: N/A Priority: Normal
NCT ID: NCT01865201 Org: User:
Start: 03/31/09 End: 09/30/12 Due: 09/30/13

Clinical Value of the Fertility-preserving Surgery in Cervical Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05806125 Org: User:
Start: 01/01/23 End: 12/01/24 Due: 12/01/25

Ketogenic Diet in Pediatric Intractable Epilepsy

Phase: N/A Priority: Normal
NCT ID: NCT06310954 Org: User:
Start: 08/11/22 End: 04/30/24 Due: 04/30/25

Arsenic Trioxide With MAPK Inhibitors and Chemotherapy for Stage 4/M Neuroblastoma

Phase: N/A Priority: Normal
NCT ID: NCT06933394 Org: User:
Start: 05/01/25 End: 05/01/31 Due: 05/01/32

HCQ+ADC vs ADC in the Treatment of Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06328387 Org: User:
Start: 01/29/24 End: 03/01/26 Due: 03/01/27

Second Ejaculate and IUI

Phase: N/A Priority: Normal
NCT ID: NCT05173038 Org: User:
Start: 05/01/22 End: 12/30/25 Due: 12/30/26

Observation Alone for Mild Non-Lactational Mastitis

Phase: N/A Priority: Normal
NCT ID: NCT06665399 Org: User:
Start: 09/11/24 End: 12/31/27 Due: 12/31/28

Effect and Safety of Apatinib on Radiation-Induced Brain Injury

Phase: N/A Priority: Normal
NCT ID: NCT04152681 Org: User:
Start: 10/17/19 End: 03/31/20 Due: 03/31/21

Postoperative Adjuvant Therapy of Donafenib for Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06581315 Org: User:
Start: 08/28/24 End: 08/30/32 Due: 08/30/33

The Effect of Donepezil in Radiotherapy-related Cognitive Impairment.

Phase: N/A Priority: Normal
NCT ID: NCT03907371 Org: User:
Start: 05/01/19 End: 12/31/22 Due: 12/31/23

A Prospective Observational Study of Sepsis

Phase: N/A Priority: Normal
NCT ID: NCT05309889 Org: User:
Start: 05/12/22 End: 06/30/23 Due: 06/30/24

Prolonged Progesterone to Prevent Preterm Birth From IVF - ET

Phase: N/A Priority: Normal
NCT ID: NCT05787509 Org: User:
Start: 04/01/23 End: 02/28/25 Due: 02/28/26

AI-Based Multimodal Multi-tasks Analysis Reveals Tumor Molecular Heterogeneity, Predicts Preoperative Lymph Node Metastasis and Prognosis in Papillary Thyroid Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06241092 Org: User:
Start: 04/01/24 End: 01/20/25 Due: 01/20/26

Outcomes of First-line Olaparib Mono-maintenance therapy-a Multicenter, Retrospective Study Using Data From Real-world Clinical Setting

Phase: N/A Priority: Normal
NCT ID: NCT05153603 Org: User:
Start: 04/30/22 End: 12/31/22 Due: 12/31/23

Study on Consistency Evaluation for Drug Sensitivity of Patient-Derived Organoid Model From Cholangiocarcinoma Patients

Phase: N/A Priority: Normal
NCT ID: NCT05634694 Org: User:
Start: 11/30/22 End: 12/01/24 Due: 12/01/25

Neoadjuvant Sintilimab Combined With Reduction of Cycles of Chemotherapy in Resectable Oral Cavity or Oropharyngeal Squamous Cell Carcinoma (OOC-002)

Phase: N/A Priority: Normal
NCT ID: NCT05098119 Org: User:
Start: 09/16/21 End: 09/16/28 Due: 09/16/29

Efficacy and Safety of Leuprorelin 3M in Premenopausal Women With Hormone Receptor-positive Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04891731 Org: User:
Start: 05/31/21 End: 09/30/23 Due: 09/30/24

Sintilimab Plus FOLFIRI as Salvage Therapy for Patients With Advanced Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06365008 Org: User:
Start: 04/08/24 End: 09/30/27 Due: 09/30/28

Administration of Hyperthermic Intraperitoneal Chemotherapy in the General Ward

Phase: N/A Priority: Normal
NCT ID: NCT06277947 Org: User:
Start: 02/29/24 End: 05/31/25 Due: 05/31/26

Treateament of Newly Diagnosed Acute Monocytic Leukemia in Children

Phase: N/A Priority: Normal
NCT ID: NCT05313958 Org: User:
Start: 12/01/21 End: 03/30/26 Due: 03/30/27

Clinical Value of Breast High-Resolution MR Ductography in Patients With Pathological Nipple Discharge

Phase: N/A Priority: Normal
NCT ID: NCT05812040 Org: User:
Start: 03/02/23 End: 05/30/24 Due: 05/30/25

The Efficacy of Radiomics to Predict Tumor Microenvironment Markers and Comprehensive Therapy for Bladder Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06381895 Org: User:
Start: 05/30/23 End: 02/20/24 Due: 02/20/25

Clinical Study on the Treatment of Type I Neurofibromatosis With Smeitinib Hydrosulfate Capsule

Phase: N/A Priority: Normal
NCT ID: NCT06620354 Org: User:
Start: 09/30/24 End: 12/31/26 Due: 12/31/27

Treatment of Mandibular Bone Cyst by Navigation and Endoscopy

Phase: N/A Priority: Normal
NCT ID: NCT06567535 Org: User:
Start: 08/20/24 End: 12/30/26 Due: 12/30/27